{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:42:21Z","timestamp":1790833341820,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,3,30]],"date-time":"2006-03-30T00:00:00Z","timestamp":1143676800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1007\/s00213-006-0356-9","type":"journal-article","created":{"date-parts":[[2006,3,29]],"date-time":"2006-03-29T03:55:18Z","timestamp":1143604518000},"page":"226-234","source":"Crossref","is-referenced-by-count":105,"title":["Interactions between THC and cannabidiol in mouse models of cannabinoid activity"],"prefix":"10.1007","volume":"186","author":[{"given":"S. A.","family":"Varvel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. L.","family":"Wiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. T.","family":"Bridgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. H.","family":"Lichtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. R.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,3,30]]},"reference":[{"key":"356_CR1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.2042-7158.1974.tb09240.x","volume":"26","author":"PF Anderson","year":"1974","unstructured":"Anderson PF, Jackson DM, Chesher GB (1974) Interaction of \u03949-tetrahydrocannabinol and cannabidiol on intestinal motility in mice. J Pharm Pharmacol 26:136\u2013137","journal-title":"J Pharm Pharmacol"},{"key":"356_CR2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.pain.2004.09.013","volume":"112","author":"JS Berman","year":"2004","unstructured":"Berman JS, Symonds C, Birch R (2004) Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial. Pain 112:299\u2013306","journal-title":"Pain"},{"key":"356_CR3","unstructured":"Bliss CI (1967) Statistics in biology; statistical methods for research in the natural sciences. McGraw-Hill"},{"key":"356_CR4","first-page":"663","volume":"7","author":"LA Borgen","year":"1974","unstructured":"Borgen LA, Davis WM (1974) Cannabidiol interaction with \u03949-tetrahydrocannabinol. Res Commun Chem Pathol Pharmacol 7:663\u2013670","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"356_CR5","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0006-2952(93)90286-6","volume":"45","author":"LM Bornheim","year":"1993","unstructured":"Bornheim LM, Everhart ET, Li J, Correia MA (1993) Characterization of cannabidiol-mediated cytochrome P450 inactivation. Biochem Pharmacol 45:1323\u20131331","journal-title":"Biochem Pharmacol"},{"key":"356_CR6","first-page":"825","volume":"23","author":"LM Bornheim","year":"1995","unstructured":"Bornheim LM, Kim K, Beatrice J, Perotti Y, Benet L (1995) Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain. Drug Metab Dispos 23:825\u2013831","journal-title":"Drug Metab Dispos"},{"key":"356_CR7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00433803","volume":"72","author":"KT Brady","year":"1980","unstructured":"Brady KT, Balster RL (1980) The effects of delta 9-tetrahydrocannabinol alone and in combination with cannabidiol on fixed-interval performance in rhesus monkeys. Psychopharmacology (Berl) 72:21\u201326","journal-title":"Psychopharmacology (Berl)"},{"key":"356_CR8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1191\/1352458504ms1063oa","volume":"10","author":"CM Brady","year":"2004","unstructured":"Brady CM, DasGupta R, Dalton C, Wiseman OJ, Berkley KJ, Fowler CJ (2004) An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis. Mult Scler 10:425\u2013433","journal-title":"Mult Scler"},{"key":"356_CR9","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/sj.bjp.0704327","volume":"134","author":"T Bisogno","year":"2001","unstructured":"Bisogno T, Hanus L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I, Moriello AS, Davis JB, Mechoulam R, Di Marzo V (2001) Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol 134:825\u2013852","journal-title":"Br J Pharmacol"},{"key":"356_CR10","unstructured":"Colquhoun D (1971) Lectures on biostatistics: an introduction to statistics with applications in biology and medicine. Clarendon"},{"key":"356_CR11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.bjp.0705920","volume":"143","author":"B Costa","year":"2004","unstructured":"Costa B, Giagnoni G, Franke C, Trovato AE, Colleoni M (2004) Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation. Br J Pharmacol 143:247\u2013250","journal-title":"Br J Pharmacol"},{"key":"356_CR12","first-page":"74","volume":"72","author":"FE D'Amour","year":"1941","unstructured":"D'Amour FE, Smith DL (1941) A method for determining loss of pain sensation. J Pharm Exp Ther 72:74\u201379","journal-title":"J Pharm Exp Ther"},{"key":"356_CR13","first-page":"453","volume":"9","author":"WM Davis","year":"1974","unstructured":"Davis WM, Borgen LA (1974) Effects of cannabidiol and \u03949-tetrahydrocannabinol on operant behavior. Res Commun Chem Pathol Pharmacol 9:453\u2013462","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"356_CR14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1520\/JFS14636J","volume":"45","author":"MA ElSohly","year":"2000","unstructured":"ElSohly MA, Ross SA, Mehmedic Z, Arafat R, Yi B, Banahan BF 3rd (2000) Potency trends of delta9-THC and other cannabinoids in confiscated marijuana from 1980\u20131997. J Forensic Sci 45:24\u201330","journal-title":"J Forensic Sci"},{"key":"356_CR15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00429130","volume":"38","author":"M Fernandes","year":"1974","unstructured":"Fernandes M, Schabarek A, Coper H, Hill R (1974) Modification of \u03949-THC actions by cannabinol and cannabidiol in the rat. Psychopharmacologia 38:329\u2013338","journal-title":"Psychopharmacologia"},{"key":"356_CR16","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.0953-816X.2004.03177.x","volume":"19","author":"DP Finn","year":"2004","unstructured":"Finn DP, Beckett SR, Roe CH, Madjd A, Fone KC, Kendall DA, Marsden CA, Chapman V (2004) Effects of coadministration of cannabinoids and morphine on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent pain. Eur J Neurosci 19:678\u2013686","journal-title":"Eur J Neurosci"},{"key":"356_CR17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00421075","volume":"41","author":"MT Ham","year":"1975","unstructured":"Ham MT, De Jong Y (1975) Absence of interaction between \u03949-tetrahydrocannabinol (\u03949-THC) and cannabidiol (CBD) in aggression, muscle control and body temperature experiments in mice. Psychopharmacologia 41:169\u2013174","journal-title":"Psychopharmacologia"},{"key":"356_CR18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1749-6632.2000.tb06193.x","volume":"899","author":"AJ Hampson","year":"2000","unstructured":"Hampson AJ, Grimaldi M, Lolic M, Wink D, Rosenthal R, Axelrod J (2000) Neuroprotective antioxidants from marijuana. Ann N Y Acad Sci 899:274\u2013282","journal-title":"Ann N Y Acad Sci"},{"key":"356_CR19","first-page":"33","volume-title":"Marijuana in science and medicine","author":"DJ Harvey","year":"198","unstructured":"Harvey DJ (1984) Chemistry, metabolism, and pharmacokinetics of the cannabinoids. In: Nahas GG (ed) Marijuana in science and medicine. Raven, New York, NY, pp 33\u2013107"},{"key":"356_CR20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/00498259609046707","volume":"26","author":"W Jaeger","year":"1996","unstructured":"Jaeger W, Benet LZ, Bornheim LM (1996) Inhibition of cyclosporine and tetrahydrocannabinol metabolism by cannabidiol in mouse and human microsomes. Xenobiotica 26:275\u2013284","journal-title":"Xenobiotica"},{"key":"356_CR21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1476-5381.1972.tb08092.x","volume":"45","author":"G Jones","year":"1972","unstructured":"Jones G, Pertwee RG (1972) A metabolic interaction in vivo between cannabidiol and 1-tetrahydrocannabinol. Br J Pharmacol 45:375\u2013377","journal-title":"Br J Pharmacol"},{"key":"356_CR22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00428793","volume":"33","author":"IG Karniol","year":"1973","unstructured":"Karniol IG, Carlini EA (1973) Pharmacological interaction between cannabidiol and \u03949-tetrahydrocannabinol. Psychopharmacologia 33:53\u201370","journal-title":"Psychopharmacologia"},{"key":"356_CR23","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0014-2999(74)90129-0","volume":"28","author":"IG Karniol","year":"1974","unstructured":"Karniol IG, Shirakawa I, Kasinaki N, Carlini EA (1974) Cannabidiol interferes with the effects of \u03949-tetrahydrocannabinol in man. Eur J Pharmacol 28:172\u2013177","journal-title":"Eur J Pharmacol"},{"key":"356_CR24","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1007\/BF01945772","volume":"31","author":"S Levy","year":"1975","unstructured":"Levy S, McCallum NK (1975) Cannabidiol and its pharmacokinetic interaction with delta1-tetrahydrocannabinol. Experientia 31:1268\u20131269","journal-title":"Experientia"},{"key":"356_CR25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0376-8716(00)00205-2","volume":"63","author":"AH Lichtman","year":"2001","unstructured":"Lichtman AH, Poklis JL, Poklis A, Wilson DM, Martin BR (2001) The pharmacological activity of inhalation exposure to marijuana smoke in mice. Drug Alcohol Depend 63:107\u2013116","journal-title":"Drug Alcohol Depend"},{"key":"356_CR26","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.0022-3042.2001.00716.x","volume":"80","author":"G Marsicano","year":"2002","unstructured":"Marsicano G, Moosmann B, Hermann H, Lutz B, Behl C (2002) Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1. J Neurochem 80:448\u2013456","journal-title":"J Neurochem"},{"key":"356_CR27","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1002\/j.1552-4604.2002.tb05998.x","volume":"42","author":"R Mechoulam","year":"2002","unstructured":"Mechoulam R, Parker LA, Gallily R (2002) Cannabidiol: an overview of some pharmacological aspects. J Clin Pharmacol 42:11S\u201319S","journal-title":"J Clin Pharmacol"},{"key":"356_CR28","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.jcp.0000125688.05091.8f","volume":"24","author":"AN Nicholson","year":"2004","unstructured":"Nicholson AN, Turner C, Stone BM, Robson PJ (2004) Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. J Clin Psychopharmacol 24:305\u2013313","journal-title":"J Clin Psychopharmacol"},{"key":"356_CR29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/bms.1200130206","volume":"13","author":"A Ohlsson","year":"1986","unstructured":"Ohlsson A, Lindgren JE, Andersson S, Agurell S, Gillespie H, Hollister LE (1986) Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administration. Biomed Environ Mass Spectrom 13:77\u201383","journal-title":"Biomed Environ Mass Spectrom"},{"key":"356_CR30","volume-title":"Cannabinoids","author":"R Pertwee","year":"2004","unstructured":"Pertwee R (2004) The pharmaology and therapeutic potential of cannabidiol. In: Di Marzo V (ed) Cannabinoids. Kluwer Academic, Dordrecht, Netherlands"},{"key":"356_CR31","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1476-5381.1972.tb06900.x","volume":"46","author":"RG Pertwee","year":"1972","unstructured":"Pertwee RG (1972) The ring test: a quantitative method for assessing the 'cataleptic' effect of cannabis in mice. Br J Pharmacol 46:753\u2013763","journal-title":"Br J Pharmacol"},{"key":"356_CR32","first-page":"129","volume":"74","author":"RG Pertwee","year":"1997","unstructured":"Pertwee RG (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74:129\u2013180","journal-title":"Pharmacol Ther"},{"key":"356_CR33","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0022-3565(24)35376-5","volume":"292","author":"F Rakhshan","year":"2000","unstructured":"Rakhshan F, Day TA, Blakely RD, Barker EL (2000) Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells. J Pharmacol Exp Ther 292:960\u2013967","journal-title":"J Pharmacol Exp Ther"},{"key":"356_CR34","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1212\/01.wnl.0000176753.45410.8b","volume":"65","author":"DJ Rog","year":"2005","unstructured":"Rog DJ, Nurmikko TJ, Friede T, Young CA (2005) Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology 65:812\u2013819","journal-title":"Neurology"},{"issue":"2","key":"356_CR35","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.mehy.2005.08.026","volume":"66","author":"E Russo","year":"2006","unstructured":"Russo E, Guy GW (2006) A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Med Hypotheses 66(2):234\u2013246","journal-title":"Med Hypotheses"},{"key":"356_CR36","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","volume":"30","author":"EB Russo","year":"2005","unstructured":"Russo EB, Burnett A, Hall B, Parker KK (2005) Agonistic properties of cannabidiol at 5-HT1a receptors. Neurochem Res 30:1037\u20131043","journal-title":"Neurochem Res"},{"key":"356_CR37","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00432273","volume":"61","author":"J Sanders","year":"1979","unstructured":"Sanders J, Jackson DM, Starmer GA (1979) Interactions among the cannabinoids in the antagonism of abdominal constriction response in the mouse. Psychopharmacology (Berl) 61:281\u2013285","journal-title":"Psychopharmacology (Berl)"},{"key":"356_CR38","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF00421466","volume":"40","author":"RD Sofia","year":"1975","unstructured":"Sofia RD, Vassar HB, Knobloch LC (1975) Comparative analgesic activity of various naturally occurring cannabinoids in mice and rats. Psychopharmacologia 40:285\u2013295","journal-title":"Psychopharmacologia"},{"key":"356_CR39","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1124\/jpet.104.080739","volume":"314","author":"SA Varvel","year":"2005","unstructured":"Varvel SA, Bridgen DT, Tao Q, Thomas BF, Martin BR, Lichtman AH (2005) Delta9-tetrahydrocannabinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice. J Pharmacol Exp Ther 314:329\u2013337","journal-title":"J Pharmacol Exp Ther"},{"key":"356_CR40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1191\/0269215503cr581oa","volume":"17","author":"DT Wade","year":"2003","unstructured":"Wade DT, Robson P, House H, Makela P, Aram J (2003) A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms. Clin Rehab 17:21\u201329","journal-title":"Clin Rehab"},{"key":"356_CR41","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1191\/1352458504ms1082oa","volume":"10","author":"DT Wade","year":"2004","unstructured":"Wade DT, Makela P, Robson P, House H, Bateman C (2004) Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. Mult Scler 10:434\u2013441","journal-title":"Mult Scler"},{"key":"356_CR42","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1016\/0006-2952(87)90313-3","volume":"36","author":"K Watanabe","year":"1987","unstructured":"Watanabe K, Arai M, Narimatsu S, Yamamoto I, Yoshimura H (1987) Self-catalyzed inactivation of cytochrome P-450 during microsomal metabolism of cannabidiol. Biochem Pharmacol 36:3371\u20133377","journal-title":"Biochem Pharmacol"},{"key":"356_CR43","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1248\/bpb.19.1109","volume":"19","author":"K Watanabe","year":"1996","unstructured":"Watanabe K, Kayano Y, Matsunaga T, Yamamoto I, Yoshimura H (1996) Inhibition of anandamide amidase activity in mouse brain microsomes by cannabinoids. Biol Pharm Bull 19:1109\u20131111","journal-title":"Biol Pharm Bull"},{"key":"356_CR44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF00421553","volume":"46","author":"PJ Welburn","year":"1976","unstructured":"Welburn PJ, Starmer GA, Chesher GB, Jackson DM (1976) Effect of cannabinoids on the abdominal constriction response in mice: within cannabinoid interactions. Psychopharmacologia 46:83\u201385","journal-title":"Psychopharmacologia"},{"key":"356_CR45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00432554","volume":"76","author":"AW Zuardi","year":"1982","unstructured":"Zuardi AW, Shirakawa I, Fenkelfarb E, Karniol IG (1982) Action of cannabidiol on the anxiety and other effects produced by \u03949-THC in normal subjects. Psychopharmacology (Berl) 76:245\u2013250","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-006-0356-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-006-0356-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-006-0356-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:02:52Z","timestamp":1736294572000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-006-0356-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,30]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["356"],"URL":"https:\/\/doi.org\/10.1007\/s00213-006-0356-9","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,30]]}}}